Hawaii Pacific Neuroscience Site#184 — Honolulu, Hawaii

Hawaii Pacific Neuroscience Site#184 is a clinical research site located in Honolulu, Hawaii, United States 96817.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Hawaii Pacific Neuroscience Site#184 has participated in 1 clinical trials.

Therapeutic areas: Neurobehavioral Disinhibition.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hawaii Pacific Neuroscience Site#184?

Hawaii Pacific Neuroscience Site#184 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hawaii Pacific Neuroscience Site#184 conducted?

Hawaii Pacific Neuroscience Site#184 has 1 clinical trials on record. Their work covers Neurobehavioral Disinhibition.

Is Hawaii Pacific Neuroscience Site#184 accredited by Crixeo Health?

Hawaii Pacific Neuroscience Site#184 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hawaii Pacific Neuroscience Site#184?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.